(University of Pennsylvania School of Medicine) Patients with drug-coated stents are less apt to die, have heart attacks or require extra stents or bypass surgery in the two years following placement of the stent, compared to those who receive bare metal stents, according to University of Pennsylvania School of Medicine research that will be published in the May 27 issue of the Journal of the American College of Cardiology